#ACR23 BEST Abstracts from San Diego – Day 1 From hundreds of online presentations, the poster floor and the plenary podium, here are some of the best abstracts from 11/12/23. You can spot these on Twitter by looking for the (#ACRbest) hashtag. https://t.co/h4RvFy66z9 https://t.co/LEhAUaw6Cj

Do Probiotics Improve PsA? Probiotics and gut microbiome is a hot topic in the research world and amongst patients. Often, one the questions I get after sharing the diagnosis of PsA is, “Is there anything I can eat/not eat to make this better?” #ACR23 https://t.co/aK56UXz3gs https://t.co/p2AuzcWyq9

Who gives a ‘JAK’ why and how they work, as long as they do! Several abstracts have studied the mechanism of action of JAKi in various diseases. JAKi alter many other mediators affected by the JAK STAT pathway. #ACR23 https://t.co/xqQF8SULgp https://t.co/DZtEly8GEq

Will CAR T Cells also treat RA? Dr. Jonathan Kay reports on abstract 0424 from #ACR23. https://t.co/XvNMXAFkWe https://t.co/HVvBLhqe8H

#ACR23 Daily Recap Panel - Day 1 Join our live stream panel discussion as we dive deep into the highlights and key takeaways from day one of ACR 2023. https://t.co/hApuycYzD2 https://t.co/1CD3rLLV7D

After 3 years, 25% (95% CI: 13 to 38) remained flare-free in the tapering TNFi group compared to 85% (70 to 93) in the stable TNFi group, hazard ratio for flare of 9.4 (3.9 to 22.8), ARCTIC REWIND, Kjorholt K, LB Abst#L07 #ACR23 #ACRBest @RheumNow https://t.co/fqxfU3jE0q https://t.co/J0qBeKNsEW

Palliative Care & Rheum - #ACR23 @RheumNow Consider Pall Care for Serious Illness: "high mortality risk & negatively impacts function or QoL OR strains caregivers" - thats a lot of rheum pt @HopkinsBayview-led session, always pt-centric @kekuchinad @MymaAlbaydaMD @jhrheumatology https://t.co/1j4lrkb5Ra

A memorable snap with the esteemed ACR rheumatologist, Dr. John Cush. #ACR23 ⁦@RheumNow⁩ ⁦@ruby_taparia⁩ ⁦@Amansharmapgi⁩ ⁦@eular_org⁩ @ InRheumatology @DandaDebashish @drdpshenoy @ DurgaPrasannaM1 @Amansharmapgi @ docrota @12VRavindran @abledoc https://t.co/jfIrMDq8ue

In this Ph2b RCT of TAK-279 (TYK2i), pts w/ PsA given 15mg & 30mg achieved an ACR20 response at wk 12 vs. PBO(53.3% and 54.2% vs 29.2%, both p = 0.002) ⬆️common TEAEs: Npharyngitis, URTI, headache & rash #ACR23 ABSL12 @RheumNow https://t.co/T6swJgw6vE

Burden of flare & organ damage of SLE pts from the Asia Pacific cohort: Prevalence of organ damage at BL - 39% Incidence of damage accrual: ~58 per 1000PY Pts w/ >=2 flares accrued damage Flares independently⬆️risk of damage accrual #ACR23 ABST2261 @RheumNow @rheumarhyme https://t.co/nW34sI9FdP

Auricular vagal nerve stimulation did not meaningfully improve RA disease activity. Further research of the novel intervention is required in RA, Baker MC, #ACR23 @RheumNow https://t.co/agLtRKdDTf